|
WO2012013331A2
|
|
Capsules of active pharmaceutical ingredients and polyunsaturated fatty acids for the treatment of prostate diseases
|
|
CA2781434A1
|
|
Capsules of active pharmaceutical ingredients and polyunsaturated fatty acid esters for the treatment of cardiovascular diseases
|
|
WO2011060943A1
|
|
Pharmaceutical formulations containing beta- blocking active ingredient capsules and polyunsaturated fatty acid esters
|
|
ES2363964A1
|
|
CAPSULES OF PHARMACEUTICAL ACTIVE PRINCIPLES AND ESTERS OF POLYINSATURATED FATTY ACIDS.
|
|
ES2344674A1
|
|
INJECTABLE PHARMACEUTICAL COMPOSITION OF TAXANOS.
|
|
ES2324009A1
|
|
PHARMACEUTICAL COMPOSITION OF SUSTAINED RELEASE OF SOMATOSTATINE OR AN ANALOG OF HIS.
|
|
ES2319054A1
|
|
ORAL PHARMACEUTICAL COMPOSITION OF DESMOPRESINA.
|
|
ES2255426A1
|
|
PHARMACEUTICAL FORMULATION THAT INCLUDES MICROCAPSULES OF STATINS SUSPENDED IN ESTER ALKYLS OF POLYINSATURATED FATTY ACIDS (PUFA).
|
